Welcome to our dedicated page for SAFRAN SA UNSPON/ ADR news (Ticker: SAFRY), a resource for investors and traders seeking the latest updates and insights on SAFRAN SA UNSPON/ ADR stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect SAFRAN SA UNSPON/ ADR's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of SAFRAN SA UNSPON/ ADR's position in the market.
Safran Defense & Space (SAFRY) has secured a contract from Bell Textron to provide flight testing solutions for six aircraft under the U.S. Army's Future Long Range Assault Aircraft (FLRAA) program. The company will deliver comprehensive onboard and ground testing solutions, focusing on data acquisition, recording, and analysis capabilities.
The FLRAA program, developed by Bell, features a tiltrotor aircraft combining helicopter-like vertical takeoff and landing capabilities with twin-turboprop aircraft speed and range. This development is important for the Army's future air mobility strategy.
Safran, a global high-technology group with €27.3 billion in sales (2024) and 100,000 employees, operates in aviation, defense, and space markets. The company maintains leadership positions in its core markets and is listed on Euronext Paris as part of the CAC 40 and Euro Stoxx 50 indices.